TCTR20220720001已完成4 期
Immunogenicity and safety of CoronaVac vaccine (Covid-19 vaccine) in Thai people with underlying disease
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 385
研究概览
简要总结
need to be explored
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. age more than 18 years old 2. Anti-SAR-CoV-2 negative 3. diabetes mellitus or 4. cirrhosis or 5. solid cancer or 6. hematologic malignancy or 7. chronic kidney disease (GFR <60 ml/mi/1.73 m2) 8. rheumatological disease or 9. cardiovascular disease
排除标准
- •1. previous covid-19 vaccination 2. prior other vaccine in 14 days 3. pregnancy 4. lactation
研究者
相似试验
Unknown
4 期
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineRotavirusNCT02153866Sichuan Center for Disease Control and Prevention2,800
撤回
1 期
Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus VaccineVenezuelan Equine EncephalitisNCT00109304DynPort Vaccine Company LLC, A GDIT Company
已完成
3 期
Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza VaccineCoronavirus Disease 2019NCT05107375Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.299
Unknown
3 期
Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Coronavirus Disease 2019NCT05128643Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.300
已完成
4 期
Immunogenicity After COVID-19 Vaccines in Adapted SchedulesCoronavirus Disease 2019COVID-19NCT06189040Universiteit Antwerpen580